Cyclosporin C is the main antifungal compound produced by Acremonium luzulae

Applied and Environmental Microbiology

Volumn 63, Issue 5, 1997, Pages 1739-1743

  Moussaïf, Mustapha ^a   Jacques, Philippe ^a   Schaarwächter, Peter ^b   Budzikiewicz, Herbert ^b   Thonart, Philippe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYCLOSPORIN C;

ACREMONIUM; ANTIFUNGAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG PURIFICATION; FRUIT; FUNGUS CULTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0030903373     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.63.5.1739-1743.1997     Document Type: Article

References (41)

1. Aarnio, T. H., and S. N. Agathos. 1989. Production of extracellular enzymes and cyclosporin by Tolypocladium inflatum and morphologically related fungi. Biotechnol. Lett. 11:759-764.
2. Bach, J. F. 1989. Cyclosporine in autoimmune diseases. Transplant. Proc. 21(Suppl. 1):97-101.
3. Bellavita, N. C., P. Ceccherelli, and M. Raffaele. 1970. Structure du virescenoside C, nouveau métabolite de Oospora virescens (Link) Wallr. Eur. J. Biochem. 15:356-359.
4. Bellavita, N. C., P. Ceccherelli, R. Fringuelli, and M. Ribaldi. 1975. Ascochlorin: a terpenoid metabolite from Acremonium luzulae. Phytochemistry 14:807.
5. Berdy, J., A. Aszalos, M. Bostian, and K. L. McNitt. 1981. Small (microbial) terpenes, p. 93-134. In J. Berdy, A. Aszalos, M. Bostian, and K. L. McNitt (ed.), Handbook of antibiotic compounds, vol. VI. CRC Press, Inc. Boca Raton, Fla.
6. Billich, A., and R. Zocher. 1987. Enzymatic synthesis of cyclosporin A. J. Biol. Chem. 262:17258-17259.
7. Borel, J. F. 1989. Pharmacology of cyclosporine (Sandimmun). IV. Pharmacological properties in vivo. Pharmacol. Rev. 41:259-371.
8. Borel, J. F. 1986. Cyclosporin and its future. Prog. Allergy 38:9-18.
9. Borel, J. F., C. Feurer, H. U. Gubler, and H. Stähelin. 1976. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6:468-475.
10. Bram, R. J., D. T. Hung, P. K. Martin, S. L. Schreiber, and G. R. Crabtree. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760-4769.
11. Dickinson, C. H. 1968. Gliomastix Guéguen. Mycol. Pap. 115:1-27.
12. Dreyfuss, M. M. 1986. Neue Erkenntnisse aus einem pharmakologischen Pilz-screening. Sydowia 39:22-36.
13. Dreyfuss, M., E. Härri, H. Hofmann, H. Kobel, W. Pache, and H. Tscherter. 1976. Cyclosporin A and C. New metabolites from Trichoderma polysporum (Link ex Pers.) Rifai. Eur. J. Appl. Microbiol. 3:125-133.
14. Fischer, G., B. Wittmann-Liebold, K. Lang, T. Kiethaber, and F. X. Schmid. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476-478.
15. Gams, W. 1971. Tolypocladium. Eine Hyphomycetengattung mit geschwollenen Phialiden. Persoonia 6:185-191.
16. Gurusiddaiah, S., L. D. Winward, D. Burger, and S. O. Graham. 1979. Pantomycin: a new antimicrobial antibiotic. Mycologia 71:103-118.
17. Heitman, J., N. R. Mowa, and M. N. Hall. 1992. Proline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression. New Biol. 4:448-460.
18. Jacques, P., M. Ongena, I. Gwose, D. Seinsche, H. Schröder, P. Delfosse, P. Thonart, K. Taraz, and H. Budzikiewicz. 1995. Structure and characterization of isopyoverdin from Pseudomonas putida BTP1 and its relation to the biogenetic pathway leading to pyoverdins. Z. Naturforsch. Teil C 50:622-629.
19. 6 by a combination of homo- and heteronuclear two dimensional techniques. Helv. Chim. Ada 68:661-681.
20. Kleinkauf, H., and H. Von Döhren. 1990. Nonribosomal biosynthesis of peptide antibiotics. Eur. J. Biochem. 192:1-15.
21. Kobel, H., and R. Traber. 1982. Directed biosynthesis of cyclosporins. Eur. J. Appl. Microbiol. Biotechnol. 14:237-240.
22. Lawen, A., and R. Zocher. 1990. Cyclosporin synthetase. The most complex peptide synthesizing multienzyme polypeptide so far described. J. Biol. Chem. 265:11355-11360.
23. Lawen, A., R. Traber, D. Geyl, R. Zocher, and H. Kleinkauf. 1989. Cell-free biosynthesis of new cyclosporins. J. Antibiot. 40:1283-1289.
24. Maiorca, R., F. Scolari, F, Savoldi, S. Sandrini, P. Scaini, and L. Cristinelli. 1989. Cyclosporin and renal injury. Adv. Exp. Med. Biol. 252:273-284.
25. Myers, B. D. 1986. Cyclosporine nephrotoxicity. Kidney Int. 30:964-974.
26. Nakajima, H., T. Hamasaki, K. Tanaka, Y. Kimura, S.-I. Udagawa, and Y. Horie. 1988. Production of cyclosporin by fungi belonging to the genus Neocosmospora. Agric. Biol. Chem. 53:2291-2292.
27. Onions, A. H. S., and B. L. Brady. 1987. Taxonomy of Penicillium and Acremonium. Biotechnol. Handb. 1:1-36.
28. Polonsky, J., Z. Baskevitch, N. C. Bellavita, P. Ceccherelli, B. L. Buckwalter, and E. Wenkert. 1972. Carbon-13-nuclear magnetic resonance spectroscopy of naturally occurring substances. Biosynthesis of virescenosides. J. Am. Chem. Soc. 94:4369-4370.
29. Razafindralambo, H., M. Paquot, C. Hbid, P. Jacques, J. Destain, and P. Thonart. 1993. Purification of antifungal lipopeptides by reversed-phase high-performance liquid chromatography. J. Chromatogr. 639:81-85.
30. Sadeg, N., C. Pham-huy, P. Rucay, S. Righenzi, O. Halle-Pannenko, J. R. Claude, H. Bismuth, and H-T. Duc. 1993. In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21. Immunopharmacol. Immunotoxicol. 15:163-177.
31. Sadeg, N., C. Pham-huy, C. Martin, J. M. Warnet, and J. R. Claude. 1994. In vitro comparative study on nephrotoxicity of cyclosporine A, its metabolites M1, M17, M21, and its analogues cyclosporines C and D in suspensions of Rabbit renal cortical cells. Drug Chem. Toxicol. 17:93-111.
32. Sawai, K., T. Okuno, Y. Terada, Y. Harada, K. Sawamura, H. Sasaki, and S. Takau. 1981. Isolation and properties of two antifungal substances from Fusarium solani. Agric. Biol. Chem. 45:1223-1228.
33. Schmidt, B., D. Riesner, A. Lawen, and H. Kleinkauf. 1992. Cyclosporin synthetase is a 1.4 MDa multienzyme polypeptide. Re-evaluation of the molecular mass of various peptide synthetases. FEBS Lett. 307:355-360.
34. Takahashi, N., T. Hayano, and M. Suzuki. 1989. Peptidyl-prolyl cis trans isomerase is the cyclosporin A binding protein cyclophilin. Nature 337:473-475.
35. Traber, R., H. Hofmann, and H. Kobel. 1989. Cyclosporins. New analogues by precursor directed biosynthesis. J. Antibiot. 40:591-597.
36. Traber, R., H. Hofmann, H. R. Loosli, M. Ponelle, and A. Von Wartburg. 1987. Neue Cyclosporinc aus Tolypocladium inflatum. Die Cyclosporine K-Z. Helv. Chim. Acta 70:13-36.
37. Traber, R., M. Kuhn, A. Ruegger, H. Lichti, H. R. Loosli, and A. Von Wartburg. 1977. Die Struktur von Cyclosporin C. Helv. Chim. Acta 60:1247-1255.
38. Von Arx, E., M. Faupel, and M. Brugger. 1976. Das 4-4′-tetremethyl diamino-diphenylmethan Reagenz (TDM): eine Modifikation der Chloro-o-tolidin-Farbereaktion für die dünnschicht-Chromatographie. J. Chromatogr. 120:224-228.
39. Von Arx, J. A. 1986. Tolypocladium, a synonym of Beauveria. Mycotaxon 25:153-158.
40. Von Wartburg, A., and R. Traber. 1986. Chemistry of the natural cyclosporin metabolites. Prog. Allergy 38:28-45.
41. Weber, G., K. Schörgendorfer, E. Schneider-Scherzer, and E. Leitner. 1994. The peptide synthetase catalyzing cyclosporine produection in Tolypocladium niveum is encoded by a giant 45,8-kilobase open reading frame. Curr. Genet. 26:120-125.